DGAP-News: Alacris Theranostics GmbH / Key word(s): Miscellaneous/Miscellaneous ALACRIS RECEIVES GERMAN INNOVATION AWARD 2015 28.04.2015 / 13:30 --------------------------------------------------------------------- Press Release ______________________________________________________________ ALACRIS RECEIVES GERMAN INNOVATION AWARD 2015 ______________________________________________________________ Berlin, 28th April 2015 - Alacris Theranostics GmbH announced today that they have been awarded the highly renowned German Innovation Award 2015. Alacris Theranostics received the award in the category Medium-Sized Enterprises for ModCellTM, an innovative system biology-based modelling approach for personalised diagnostics, therapy and drug stratification with an initial focus on cancer. ModCellTM can predict potential effects and side effects of treatments on the basis of a detailed molecular analysis of the patient's tumor to support physicians in their decision making for an optimized therapy for each individual patient (currently in a clinical trial). In addition, ModCellTM can be used in both, biomarker identification and for the development and repositioning of drugs. By simulating drug activity in "virtual clinical trials", ModCellTM allows for a faster, more efficient drug development and approval process. The unique feature of ModCellTM is the use of a systems biology model in the field of personalised medicine which is significantly different from statistical, correlative approaches, in most cases based only on single or multiple biomarkers. The analysis of individual biomarkers allows only examination of a partial aspect of the disease. ModCellTM however, generates a computer model of a "virtual patient" on the basis of analysing the totality of the biological data and therefore helps to identify individualised, promising treatment strategies for cancer patients. "We are delighted that the jury of the German Innovation Award has honoured our innovative ModCellTM modelling approach," commented Bodo Lange, PhD, CEO of Alacris Theranostics GmbH. "The award is an important recognition of our approach and our work. This prize further encourages us to continuously develop and improve ModCellTM for achieving the best possible treatment for patients in the fight against cancer." Alacris has established its own state-of-the-art Next Generation Sequencing Laboratory in Berlin with the appropriate sequencing and data analysis capabilities in order to generate data for the modelling of patients and tumours. With the development and commercialisation of this innovation in personalised healthcare, Alacris also attracts highly qualified international young scientists to the Berlin area. Berlin plays an important role as an attractive location for researchers, companies, founders and consequently investors. About German Innovation Award In 2010, Accenture, EnBW, Evonik and Wirtschaftswoche jointly formed the initiative "The German Innovation Award" to reward German companies with outstanding, pioneering innovations that have the potential to change business and markets. The prize is awarded in three categories to large companies, medium sized enterprises and start-ups. In addition to product innovations and innovative business models, the jury also considered processes, services and outstanding organisational and marketing innovations. About Alacris Theranostics GmbH Berlin-based Alacris Theranostics (www.alacris.de), a spin-off from the Max Planck Institute for Molecular Genetics, develops new approaches in personalised medicine for cancer patient diagnosis, treatment and drug stratification. The Company is applying the systems biology approach ModCellTM to provide a "Virtual Patient" model based on genome and transcriptome information obtained by next generation sequencing, mutation and drug databases as well as complex pathway information. This "Virtual Patient" model can predict the effects of drug treatment and optimised combinatory treatments to provide the means for truly personalised medicine approaches. In addition, Alacris' "Virtual Clinical Trials" system enables the in silico analysis of drugs, thus identifying stratified patient groups with particular genetic and molecular profiles that could be targeted by a drug to allow more efficient drug development and approval. # # # Contact: Alacris Theranostics GmbH Dr Bodo Lange, CEO Fabeckstrasse 60-62 D-14195 Berlin Germany Phone: + 49 30 8431 22 510 Email: info@alacris.de www.alacris.de MC Services AG Anne Hennecke, Managing Partner Tel.: +49 211 529 252 22 Email: anne.hennecke@mc-services.eu --------------------------------------------------------------------- 28.04.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- 349739 28.04.2015
DGAP-News: ALACRIS RECEIVES GERMAN INNOVATION AWARD 2015
Top 10 Most Recent News Articles
Reel Wheels: Hollywood's Iconic Car Collection Unveiled
Rolling Out the Legends: A Peek Inside Reel Wheels Picture something that screams Hollywood. Now, give it wheels, maybe some wings too. That's what Reel Wheels Entertainment has laid out—a mind-boggling assortment of film and TV vehicles. Released on September 30, 2026, this collection is a treasure trove of Hollywood's on-screen memorabilia, and they're not just...
Continue Reading
Roof Replacement Timelines: Key Insights for PA Homeowners
There's no denying it; having a roof over your head is one thing, but knowing when to replace it is a whole other ballgame. In Pennsylvania, where the weather loves to throw curveballs, making the right call on roof replacement can save a heap of trouble down the road. Thanks to Miguel Cornejo and his insights in HelloNation’s latest rundown, we get a clearer picture of...
Continue Reading
Vortex Expands UK Reach with Torrent Acquisition Boost
Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...
Continue Reading
EPR Fireworks, Schedule2.IT Enhance EMS Integration
Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...
Continue Reading
OSHA and NSC Forge Alliance to Prevent Worksite Tragedies
Forging Ahead With a Crucial Collaboration Ins, outs, ups, and downs—safety shouldn’t get lost in the shuffle, but it does. In steps the National Serious Injury and Fatality Prevention Alliance, a fresh partnership convened by OSHA with the National Safety Council—hop on board or get left behind mindsets. We’re talking about real, heads-down, hard-hitting actions...
Continue Reading
Medicare Payment Proposal Faces Doctor Backlash in D.C.
Why Same-Day Medicare Care Matters Imagine you're gasping for breath, struggling to find relief, and then being told to wait weeks for care. It's not just an inconvenience; it's a health hazard. This isn't some arbitrary tale—it's the gritty reality for folks relying on same-day care. A group of docs and advocates recently stormed Capitol Hill sounding the alarm about a...
Continue Reading
Local Expertise in Real Estate: Key to Success?
Local Market Know-How: A Seller's Best Asset So you're thinking about selling your home in North Carolina, huh? Here's a tip—get yourself a local real estate pro who knows the ins and outs of your neighborhood like the back of their hand. Michael McCollum, a prominent voice from Reidsville, NC, highlights how crucial local expertise can be in navigating the widely...
Continue Reading
FSS Unveils AI Tool to Simplify Bankruptcy Cases
AI Revolution in Bankruptcy Management Alright, folks, there's a fresh breeze blowing in the bankruptcy management world, and it bears the acronym FSS. Financial Software Solutions is rolling out its innovative FSS Intelligence Engine. This little powerhouse aims to turn what used to be a gut-wrenching slog through mountains of paperwork into a slick, automated process....
Continue Reading
JennAir and Cosentino Introduce Seamless Kitchen Aesthetics
It's not every day that the kitchen landscape gets a bold makeover, but JennAir and Cosentino seem to think it's time. Introducing their latest splash, the JennAir x Dekton panel collection is here to redefine what luxury kitchens can look like—an embodiment of seamless beauty that’s more sculpture than cooking space. Elevating Kitchen Design So, what's the buzz about...
Continue Reading
University of Phoenix Grads Shine in Job Readiness
University of Phoenix Graduates Proving Their Worth Dive straight into the world of University of Phoenix grads, and you're looking at some folks who seem to have the workplace game figured out. A fresh Harris Poll, done on behalf of the University itself, paints a rosy picture of these graduates from the eyes of those who actually supervise them. Turns out, managers are...
Continue ReadingTop 5 Most Recently Viewed Articles
How a $1000 Investment in ON Semiconductor Could Have Grown
The Growth Journey of ON Semiconductor Over the past ten years, ON Semiconductor (NASDAQ: ON) has demonstrated remarkable performance, boasting an average annual return of 15.66%. This rate surpasses the market by 4.5% on an annualized basis, showcasing the company's ability to thrive in a competitive landscape. Currently, ON Semiconductor holds a market capitalization of...
Continue Reading
Mallinckrodt plc Announces New Date for Financial Results Release
Important Update from Mallinckrodt plc Mallinckrodt plc, a well-established global specialty pharmaceutical company, has recently shared that it will release its financial results for the fourth quarter and fiscal year 2024 on March 13, 2025, ahead of market opening. The rescheduling of this key announcement is part of their commitment to keeping investors informed....
Continue Reading
Bullish Earnings Surge: Key Financial Highlights and Trends
Financial Performance Highlights Bullish (NYSE: BLSH) has recently announced its third-quarter financial results, showcasing a solid performance in a challenging market environment. The revenue for the quarter soared to $76.5 million, significantly surpassing the analysts' expectations of $71.2 million. This impressive feat reflects the company's robust strategy and...
Continue Reading
Unveiling Whale Strategies Behind RH's Stock Activity
Unveiling Whale Strategies Behind RH's Stock Activity Recently, investors with considerable capital have taken a bullish approach toward RH, a prominent player in the luxury furniture market. This trend has caught the attention of retail traders eager to understand the waves made by these significant trades. Publicly available options history has revealed intriguing...
Continue Reading
How Cat In A Dog's World Coin Surged Amid Market Pullback
Cat In A Dog's World Coin Defies Market Trends The feline-themed cryptocurrency, Cat In A Dog's World (MEW), emerged victorious against the recent market pullback that impacted the broader meme coin sector. On a day when many tokens faced declines, MEW managed to spike over 6%, showcasing considerable resilience and strength in a challenging environment. Significant Gains...
Continue Reading